| A Bitter Pill: The High Cost of Specialty Drugs | |
The good news: Pharmaceutical companies are developing a range of drugs to treat diseases that are chronic and/or rare. The bad news: Their high (some might say outrageous) cost. [September 2015, 713 word article] |
|
| Recommend to a Friend | |
|---|---|
 Share by E-mail Twitter™ Facebook™ |
|
Loading...